Prosensa Holding B.V. Logo

Prosensa to Present at Wedbush 2013 Life Sciences Management Access Conference

| Source: Prosensa Holding N.V.

Leiden, The Netherlands, Aug. 6, 2013 (GLOBE NEWSWIRE) -- Prosensa Holding N.V. (NASDAQ: RNA) today announced that Hans GCP Schikan, Chief Executive Officer, will present a corporate overview at the Wedbush 2013 Life Sciences Management Access Conference in New York, NY on Tuesday, August 13, 2013 at 1:55pm ET. A live webcast of the presentation can be accessed through the Investor section of the Prosensa corporate website at and will be archived for 90 days.

About Prosensa Holding N.V.

Prosensa (NASDAQ: RNA) is a Dutch biotechnology company engaged in the discovery and development of RNA-modulating therapeutics for the treatment of genetic disorders. Its primary focus is on rare neuromuscular and neurodegenerative disorders with a large unmet medical need, including Duchenne muscular dystrophy, myotonic dystrophy and Huntington's disease.

Prosensa Holding N.V.
Celia Economides
Director IR & Corporate Communications
Phone: +1 917 941 9059

The Trout Group
Chad Rubin
Phone: + 1 646 378 2900